Cancer Committee | Membership
This list is current as of 10 February 2022.
|Name||TCPS 2 Roles & Specialties||City|
|Lauren Birks, PhD||Community Member (Population and Public Health)||Calgary|
|Ellen Burgess, MD||Scientific / Ethics (Nephrology / Pediatrics / Ethics)||Calgary|
|Karen Campbell,||Community Member||Edmonton|
|Susan Chafe, MD||Scientific (Pediatric Radiation Oncology / Law)||Edmonton|
|Sambasivarao Damaraju, PhD||Scientific (Cancer Genetics / Pharmacogenetics / Precision Medicine)||Edmonton|
|Brenda Davis, LLM||Privacy / Law||Edmonton|
|Sunil Desai, MD||Scientific (Pediatric Hematology / Oncology)||Edmonton|
|Dale Dewhurst, LLM, JD (Chair)||Ethics / Law (Virtue Ethics / Access to Justice)||Edmonton|
|Katherine Duthie, PhD||Ethics (Clinical Ethics)||Edmonton|
|Alysa Fairchild, MD, FRCPC||Scientific (Radiation Oncology)||Edmonton|
|David Fenton, MD, FRCPC||Scientific (Medical Oncology)||Edmonton|
|Sunita Ghosh, PhD||Scientific (Biostatistics)||Edmonton|
|Desiree Hao, MD||Scientific (Medical Oncology)||Calgary|
|Joanne Hewitt, PhD||Scientific (Advanced Practice Nursing)||St. Albert|
|Eve Hildebrand, BA||Community Member||Edmonton|
|Lloyd Jamie Hodge, PEng.||Community Member||Calgary|
|Richard Lee-Ying, MD||Scientific (Medical Oncology)||Calgary|
|Mary Marshall, LLM||Privacy / Law||Edmonton|
|Chris McTavish, PhD||Scientific (Ethics)||Edmonton|
|Beverley O’Brien, PhD||Ethics (Nursing)||Edmonton|
|Robert Pearcey, MD||Scientific (Radiation Oncology)||Edmonton|
|Guy Pelletier, PhD||Scientific (Psychosocial Oncology)||Calgary|
|Gloria Roldán Urgoiti, MD, FRCPC||Scientific (Medical Oncology)||Calgary|
|Mary-Pat Schlosser, MD||Scientific (Pediatric Palliative Care)||Edmonton|
|Fiona Schulte, PhD||Scientific (Pediatric Psychosocial Oncology)||Calgary|
|Michael Smylie, MD||Scientific (Medical Oncology)||Edmonton|
|Jan Storek, MD||Scientific (Oncology, Microbiology, Immunology/ Infectious Diseases)||Calgary|
|Keith Tankel, MD||Scientific (Radiation Oncology)||Edmonton|
|Andrew Robert Turner, MD||Scientific (Medical Oncology / Hematology)||Edmonton|
|Raul Urtasun, MD (Vice Chair)||Scientific (Radiation Oncology)||Edmonton|
|Peter Venner, MD (Vice Chair)||Scientific (Medical Oncology)||Edmonton|
|John Walker, MD||Scientific (Medical Oncology)||Edmonton|
|Brent Windwick, QC, LLM||Law (Health Law)||Edmonton|
|Jackson Wu, MD (Vice Chair)||Scientific (Radiation Oncology)||Calgary|
|Xiaofu Zhu, MD||Scientific (Medical Oncology)||Edmonton|
The HREBA Cancer Committee is constituted and operates in accordance with the:
– Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2);
– Alberta Health Information Act (HIA);
– Good Clinical Practice (GCP) Guidelines of the International Conference on Harmonization (ICH);
– Health Canada’s Food and Drug Regulations (FDR), Part C, Division 5.
The committee is registered with the U.S Department of Health and Human Services, Office for Human Research Protections (OHRP), IRB # 00009687.
The HREBA-CC is one of three committees which comprise the HIA-designated Health Research Ethics Board of Alberta. Since the three committees operate as one Research Ethics Board, members from one committee may attend another committee’s meeting when their expertise is required. This ensures that members in attendance have the specific expertise, relevant competence and knowledge necessary to provide an adequate research ethics review of the proposals under consideration.
The majority of the committee members are Canadian citizens or permanent residents under the Immigration and Refugee Protection Act. Members named as Principal Investigators or Co-investigators on a study that is under review do not participate in discussions related to, nor vote on, such studies when they are presented; this applies to initial and continuing reviews.
A pdf version of this list, as well as previous lists of HREBA members and committee composition, can be found here.